Safety of patients reason for FDA black box warning on droperidol.
Publication
, Journal Article
Habib, AS; Gan, TJ
Published in: Anesth Analg
February 2004
Duke Scholars
Published In
Anesth Analg
DOI
ISSN
0003-2999
Publication Date
February 2004
Volume
98
Issue
2
Start / End Page
552
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Torsades de Pointes
- Droperidol
- Arrhythmias, Cardiac
- Antiemetics
- Anesthesiology
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Habib, A. S., & Gan, T. J. (2004). Safety of patients reason for FDA black box warning on droperidol. Anesth Analg, 98(2), 552. https://doi.org/10.1213/01.ANE.0000077705.55641.6B
Habib, Ashraf S., and Tong J. Gan. “Safety of patients reason for FDA black box warning on droperidol.” Anesth Analg 98, no. 2 (February 2004): 552. https://doi.org/10.1213/01.ANE.0000077705.55641.6B.
Habib AS, Gan TJ. Safety of patients reason for FDA black box warning on droperidol. Anesth Analg. 2004 Feb;98(2):552.
Habib, Ashraf S., and Tong J. Gan. “Safety of patients reason for FDA black box warning on droperidol.” Anesth Analg, vol. 98, no. 2, Feb. 2004, p. 552. Pubmed, doi:10.1213/01.ANE.0000077705.55641.6B.
Habib AS, Gan TJ. Safety of patients reason for FDA black box warning on droperidol. Anesth Analg. 2004 Feb;98(2):552.
Published In
Anesth Analg
DOI
ISSN
0003-2999
Publication Date
February 2004
Volume
98
Issue
2
Start / End Page
552
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Torsades de Pointes
- Droperidol
- Arrhythmias, Cardiac
- Antiemetics
- Anesthesiology
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences